Where does Hyalex Orthopaedics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hyalex Orthopaedics, Inc. ranks #19,877 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hyalex Orthopaedics, Inc. hold?

Hyalex Orthopaedics, Inc. holds 14 US utility patents granted between 2017 and 2024, spanning 13 technology areas.

What is Hyalex Orthopaedics, Inc.'s Innovation Score?

Hyalex Orthopaedics, Inc. has an Innovation Score of 40.1 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Hyalex Orthopaedics, Inc.'s patent grant rate increasing or decreasing?

Hyalex Orthopaedics, Inc.'s recent grant velocity is +267% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Hyalex Orthopaedics, Inc.'s patents?

Hyalex Orthopaedics, Inc.'s patents average 23.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hyalex Orthopaedics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Hyalex Orthopaedics, Inc.

Q: What technology areas does Hyalex Orthopaedics, Inc. focus on?

Hyalex Orthopaedics, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 14 patents, ranking #463 of 3,082 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 13 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hyalex ranks #19,877 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 13 technology areas.

#19,877
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.1/100): 23.0
avg claims per patent: +267%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19877 · US Corporation #19,877 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,877/49,997
PHOTO-FINISH Hong Kong R&D…
CPC-FOCUS A61F · 13 areas
INNOV-PAR 40.1/100
CLAIMS-DENSE 23.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +267% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hong Kong R&D Centre for Logistics and Supply Chain Management Enabling Technologies Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hyalex’s 40.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (23%) Velocity 4.2 pts (10%) Breadth 12.7 pts (32%) Claim depth 13.8 pts (34%)

Qualcomm Incorporated · highest

85
CERN—EUROPEAN… · near

40
Hyalex Orthopaedics · this assignee

40
Rockwell Automation… · near

40
Secretlab SG Pte · near

40
Verizon Telematics · near

40
3D Lighting… · lowest

7

What this shows Hyalex's Innovation Score is 40.1/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hyalex?

Each dot is one of Hyalex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hyalex’s own 23.0 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hyalex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hyalex's grants concentrate

Hyalex Orthopaedics, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2017. By volume, Hyalex sits between Hong Kong R&D Centre for Logistics and Supply Chain Management Enabling Technologies Limited and Hyundai Electric & Energy Systems Co., Ltd..

Hyalex's three-year grant acceleration

Hyalex Orthopaedics, Inc. shows 5 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hong Kong R&D Cen…

14
Horizon

14
Hourglass Medical

14
Huwais IP Holding

14
Hyperfine

14
Hyperion Core

14
Hysitron

14
Hyundai Electric…

14
Hyalex Orthopaedi… ◀

14

What this shows Hyalex holds 14 patents at rank #19,876, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hyalex

By rank, the assignees closest to #19,876 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Hyalex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hyalex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Hyalex ranks #463 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

CERN—EUROPEAN Organization FOR Nuclear Research 40 Rockwell Automation Safety AG 40 Secretlab SG Pte. Ltd. 40 Verizon Telematics Inc. 40

Hyalex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Hyalex Orthopaedics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	7.1%
2019	2	14.3%
2020	3	21.4%
2021	3	21.4%
2022	1	7.1%
2023	3	21.4%
2024	1	7.1%

Which technologies does Hyalex Orthopaedics, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 11

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 8

C08L - Compositions OF Macromolecular Compounds 8

F05D - Indexing Scheme FOR Aspects Relating TO Non-positive-displacement Machines OR Engines, Gas-turbines OR Jet-propulsion Plants 5

A61B - DIAGNOSIS; SURGERY; Identification 5

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 5

F01D - Non-positive Displacement Machines OR Engines, e.g. Steam Turbines 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 3

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hyalex Orthopaedics, Inc.'s patent record in context - here's where to go next.

Hyalex Orthopaedics, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #19,877 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hyalex Orthopaedics, Inc. against Hong Kong R&D Centre for Logistics and Supply Chain Management Enabling Technologies Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.